Lung Cancer Immunotherapy Triggers Life-Threatening Multi-System Immune Reactions in One Patient
A case report from Frontiers in Pharmacology describes a 74-year-old lung cancer patient who developed myositis, myocarditis and thyroiditis after ...
A case report from Frontiers in Pharmacology describes a 74-year-old lung cancer patient who developed myositis, myocarditis and thyroiditis after ...
An Ethiopian case-control study developed and internally validated a lung cancer risk model with an AUC of 0.775, while external ...
A new review reveals how lysosome–autophagy networks orchestrate lung maturation and may reshape treatment of bronchopulmonary dysplasia, cystic fibrosis, and ...
A new review argues that lung tumours run an integrated, adaptable metabolic network rather than isolated pathways, explaining growth under ...
Lung cancer remains the deadliest cancer in the United States, killing more people each year than colon, breast, and prostate ...
A new GIS-based study maps relative urban vulnerability to lung cancer across Greater Cairo, combining twenty-nine spatial indicators with a ...
For patients with EGFR-mutant lung adenocarcinoma whose cancer has already spread to the brain, third-generation EGFR-TKI drugs such as osimertinib ...
A resting-state fMRI study of 75 lung cancer patients in China found that those with comorbid depressive symptoms showed altered ...
For a decade, a single hospital in Riyadh carried the entire lung transplant burden of Saudi Arabia. Between January 2014 ...
A nationwide analysis of 8,104 Hungarian patients treated from 2013 to 2022 shows median survival of just 9.3 months with ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine